Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 6,732 results for: pAAV

Clear keywords
Showing: 6261 - 6280 of 6732 results

  3. AAV_CWSL.hSyn.DIO.Synaptophysin-GCaMP6s.P2A.mRuby3

    Plasmid
    #107737
    Purpose
    In the presence of Cre, drives neuron-specific expression of both GCaMP6s fused to the presynaptic protein synaptophysin and independently the red-fluorescent protein mRuby3.
    Depositor
    Rylan Larsen
    Insert
    synaptophysin-GCaMP6s, mRuby3
    Use
    AAV and Cre/Lox
    Expression
    Mammalian
    Promoter
    hSyn
    Available Since
    March 29, 2018
    Availability
    Academic Institutions and Nonprofits only
    107737-plasmid-map-sequence-id-207281

    Enlarge

  6. scFLARE1-p2A-eGFP

    Plasmid
    #158699
    Purpose
    Mammalian expression of scFLARE1 component bearing a p2A-eGFP as transfection marker
    Depositor
    Alice Ting
    Article
    Sanchez et al Proc Natl Acad Sci U S A. 2020 Dec 15. p
    Insert
    scFLARE1-p2A-eGFP
    Use
    AAV
    Tags
    Flag, V5. eGFP
    Expression
    Mammalian
    Mutation
    Truncated form of TEV protease (220-242 amino aciā€¦
    Promoter
    CMV
    Available Since
    Jan. 6, 2021
    Availability
    Academic Institutions and Nonprofits only
    158699-plasmid-map-sequence-id-315073

    Enlarge

  8. AiP14467 - pAAV-AiE2182m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN4467) (AAV8)

    Viral Prep
    #224043-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AiP14467 - pAAV-AiE2182m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN4467) (#224043). In addition to the viral particles, you will also receive purified AiP14467 - pAAV-AiE2182m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN4467) plasmid DNA. minBG-driven expression of SYFP2 in cortical L5_IT neurons (strong). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.
    Promoter
    minBG
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  9. AiP12828 - pAAV-AiE0456m-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2828) (AAV8)

    Viral Prep
    #224006-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AiP12828 - pAAV-AiE0456m-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2828) (#224006). In addition to the viral particles, you will also receive purified AiP12828 - pAAV-AiE0456m-minBG-SYFP2-WPRE3-BGHpA (Alias: CN2828) plasmid DNA. minBG-driven expression of SYFP2 in cortical L5_ET neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.
    Promoter
    minBG
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-CamkII-tTA-2A-E2-Crimson-WPRE-pA (AAV8)

    Viral Prep
    #183708-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CamkII-tTA-2A-E2-Crimson-WPRE-pA (#183708). In addition to the viral particles, you will also receive purified pAAV-CamkII-tTA-2A-E2-Crimson-WPRE-pA plasmid DNA. CamKIIa-driven expression of tetracycline-controlled transactivator (tTA)and E2 Crimson. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jonathan Ploski
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  11. AiP20168 - pAAV-AiE2575m-minBG-iCre-WPRE3-BGHpA (AAV1)

    Viral Prep
    #230804-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AiP20168 - pAAV-AiE2575m-minBG-iCre-WPRE3-BGHpA (#230804). In addition to the viral particles, you will also receive purified AiP20168 - pAAV-AiE2575m-minBG-iCre-WPRE3-BGHpA plasmid DNA. minBG-driven expression of iCre in specific populations of brain cells. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Bosiljka Tasic
    Article
    Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.
    Promoter
    minBG
    Available Since
    Feb. 9, 2026
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-CAG-LiLac (AAV8)

    Viral Prep
    #184570-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-LiLac (#184570). In addition to the viral particles, you will also receive purified pAAV-CAG-LiLac plasmid DNA. CAG-driven expression of lactate sensor LiLac. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gary Yellen
    Article
    Koveal et al Nat Commun. 2022 May 25;13(1):2919. doi:
    Promoter
    CAG
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-hSyn-dF-HA-KORD-IRES-mCitrine (AAV Retrograde)

    Viral Prep
    #65417-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn-dF-HA-KORD-IRES-mCitrine (#65417). In addition to the viral particles, you will also receive purified pAAV-hSyn-dF-HA-KORD-IRES-mCitrine plasmid DNA. hSyn-driven, Cre-dependent KORD expression with bicistronic mCitrine, for SALB-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Article
    Vardy et al Neuron. 2015 Apr 29. pii: S0896-6273(15)
    Promoter
    Syn
    Tags
    mCitrine
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  14. pOTTC589 - pAAV c-fos Nuc-eYFP (AAV1)

    Viral Prep
    #59133-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pOTTC589 - pAAV c-fos Nuc-eYFP (#59133). In addition to the viral particles, you will also receive purified pOTTC589 - pAAV c-fos Nuc-eYFP plasmid DNA. C-fos-driven expression of Nuc-eYFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Brandon Harvey
    Article
    Richie et al J Neurosci Methods. 2017 Jun 1;284:1-14.
    Promoter
    mFos
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE (AAV2)

    Viral Prep
    #203847-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE (#203847). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE plasmid DNA. Ef1a-driven, Flp-dependent expression of Chronos-EGFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ivo Spiegel
    Article
    Cohen-Kashi Malina et al Neuron. 2021 Jul 7;109(13):2150-2164.e5.
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-RSV-SpCas9 (AAV8)

    Viral Prep
    #85450-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-RSV-SpCas9 (#85450). In addition to the viral particles, you will also receive purified pAAV-RSV-SpCas9 plasmid DNA. RSV-driven expression of SpCas9. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hetian Lei
    Article
    Duan et al J Biol Chem. 2016 May 31. pii: jbc.M116.
    Promoter
    pRSV
    Available Since
    Jan. 14, 2026
    Availability
    Academic Institutions and Nonprofits only

  17. AiP15646: pAAV-AiE1426m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN5646) (AAV2)

    Viral Prep
    #230884-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from AiP15646: pAAV-AiE1426m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN5646) (#230884). In addition to the viral particles, you will also receive purified AiP15646: pAAV-AiE1426m_3xC2-minBG-SYFP2-WPRE3-BGHpA (Alias: CN5646) plasmid DNA. minBG-driven expression of SYFP2 in cortical and striatal Sst-Chodl neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1
    Available Since
    Nov. 14, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. AiP13780: pAAV-AiE0743m_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN3780) (AAV2)

    Viral Prep
    #214848-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from AiP13780: pAAV-AiE0743m_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN3780) (#214848). In addition to the viral particles, you will also receive purified AiP13780: pAAV-AiE0743m_3xC2-minBG-iCre(R297T)-BGHpA (Alias: CN3780) plasmid DNA. minBG-driven expression of iCre(R297T) in striatal cholinergic neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Allen Institute for Brain Science, Jonathan Ting
    Article
    Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1
    Available Since
    Nov. 14, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-hsyn-GRAB_Ado1.0med (AAV2)

    Viral Prep
    #153286-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hsyn-GRAB_Ado1.0med (#153286). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_Ado1.0med plasmid DNA. Synapsin-driven expression of GRAB_Ado1.0med adenosine sensor in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Wu et al Proc Natl Acad Sci U S A. 2023 Apr 4;120
    Promoter
    Syn
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-CaMKIIa-hChR2(E123T/T159C)-mCherry (AAV2)

    Viral Prep
    #35512-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-hChR2(E123T/T159C)-mCherry (#35512). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(E123T/T159C)-mCherry plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin E123T/T159C mutant fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Mattis et al Nat Methods. 2011 Dec 18;9(2):159-72. do
    Promoter
    CaMKII
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 6261 - 6280 of 6732 results